Emerging role of nanog in tumorigenesis and cancer stem cells.
about
Anti-Cancer Stem-like Cell Compounds in Clinical Development - An Overview and Critical AppraisalCancer stem cells (CSCs), cervical CSCs and targeted therapiesCancer Stem Cells and Macrophages: Implications in Tumor Biology and Therapeutic StrategiesCommon stemness regulators of embryonic and cancer stem cellsPotential Gene Interactions in the Cell Cycles of Gametes, Zygotes, Embryonic Stem Cells and the Development of CancerInsights into Chemoresistance of Prostate CancerInvolvement of Polo-like kinase 1 (Plk1) in quiescence regulation of cancer stem-like cells of the gastric cancer cell linesHypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m⁶A-demethylation of NANOG mRNA.The pluripotency factor NANOG promotes the formation of squamous cell carcinomasSmall putative NANOG, SOX2, and SSEA-4-positive stem cells resembling very small embryonic-like stem cells in sections of ovarian tissue in patients with ovarian cancerCore pathway mutations induce de-differentiation of murine astrocytes into glioblastoma stem cells that are sensitive to radiation but resistant to temozolomide.Targeting IκB Kinase β/NF-κB Signaling in Human Prostate Cancer by a Novel IκB Kinase β Inhibitor CmpdA.Bile acids promote diethylnitrosamine-induced hepatocellular carcinoma via increased inflammatory signaling.Palmitoylated claudin7 captured in glycolipid-enriched membrane microdomains promotes metastasis via associated transmembrane and cytosolic molecules.Androgen/androgen receptor axis maintains and promotes cancer cell stemness through direct activation of Nanog transcription in hepatocellular carcinoma.Dichloroacetate potentiates tamoxifen-induced cell death in breast cancer cells via downregulation of the epidermal growth factor receptor.Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells.ANGPTL4 Correlates with NSCLC Progression and Regulates Epithelial-Mesenchymal Transition via ERK Pathway.Gain-of-function p53 activates multiple signaling pathways to induce oncogenicity in lung cancer cells.Development of novel radiochemotherapy approaches targeting prostate tumor progenitor cells using nanohybrids.Current status in cancer cell reprogramming and its clinical implications.Approaches for targeting cancer stem cells drug resistance.RNA editing-dependent epitranscriptome diversity in cancer stem cells.Cyclooxygenase-2 regulates TGFβ-induced cancer stemness in triple-negative breast cancer.A Novel Role For Nanog As An Early Cancer Risk Marker In Patients With Laryngeal Precancerous LesionsPluripotency factor Nanog is tumorigenic by deregulating DNA damage response in somatic cells.TSSC3 represses self-renewal of osteosarcoma stem cells and Nanog expression by inhibiting the Src/Akt pathway.Radiation-resistant cancer stem-like cell properties are regulated by PTEN through the activity of nuclear β-catenin in nasopharyngeal carcinoma.Ovarian Cancer Stem Cells: Unraveling a Germline Connection.N6-methyladenosine links RNA metabolism to cancer progression.NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.Nanog interaction with the androgen receptor signaling axis induce ovarian cancer stem cell regulation: studies based on the CRISPR/Cas9 system.The dual role of N6-methyladenosine modification of RNAs is involved in human cancersPrognostic significance of NANOG expression in solid tumors: a meta-analysis
P2860
Q26744536-F51BB479-0F09-4A8A-8F68-5C56511E87B7Q26747144-2F4D01B5-5EC9-408F-A7DC-E1CA40CAAE42Q26765342-3C6047A7-168F-470D-A273-660D011574CFQ26777882-74FBFFDB-3103-4686-8737-1C355F5E0FFEQ26781101-AB4DC827-8D60-4A8A-9AE7-574FD0581F06Q26795589-24379F57-C6EB-45D9-9CEB-F476090601D6Q33914062-E770E56B-E80F-455E-AE57-BD7E2EE093EDQ34519307-76F771A4-54C3-4192-BF3A-784DE092A2FFQ35623354-3CBEE36D-D5C6-4430-97E3-1AD8A6E78F6FQ36651828-8AB1C959-4D04-4BAA-9666-822AD589E9B4Q36977690-B2C98C49-E876-48D6-9EA9-EA35EB234071Q37075277-3EAC9039-A7AF-4490-B918-EC95A6DE145CQ37139504-FCEB7003-A52D-4E63-9DD2-9554DA383FCDQ37327571-CE4686F0-1F10-413A-8B66-AF63F14C7674Q37392841-32F96C39-6760-4943-BB36-0464A4E298BBQ37644942-3B3B08F9-8E6C-4389-8659-86EE5DC0EF3BQ37662078-21FF62CA-2035-43BB-90C6-DB187A148E17Q38771817-92C31796-C977-4B9F-AD56-7738B24CAEB0Q38830254-1D3D473C-B8A2-4744-BA8B-2F9B5B8F4E5BQ38865548-EE16B4DC-B2E3-407B-9CB2-A613AF59287FQ38952695-EA70FB15-F574-48C2-8238-66467BB94866Q38971795-27278315-C2E9-4E22-8B54-3F7C729716FDQ39247132-51488C41-733C-4971-A3CB-D400B2C1BAE8Q40814411-B0F96835-8526-4E26-836E-098070EE4118Q41319418-6B7FF1B6-CABE-411C-AD66-009A63495017Q45073527-0ECF2631-F266-4302-B210-4ACC824975C4Q45925124-A954DE11-ED9D-49C4-A937-55FAECB3AC5BQ47140610-26E3FF62-6112-4239-857A-01C8F362D7D4Q47594107-EAA57531-43DE-4225-8CFF-F8D346C847C6Q49646778-D03DEA5A-7FE5-46FE-AFC5-B2650DC3692BQ52717052-F25692FA-3669-4E43-8296-AB6699CECB10Q55246092-C49F6FA1-B8A1-4A51-8112-AAF9634C888AQ57141167-20368F7E-C32A-4976-990E-A1CCB5CEA52AQ58761505-08CB9E82-2DB3-4C80-8103-D7B2D28882EA
P2860
Emerging role of nanog in tumorigenesis and cancer stem cells.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Emerging role of nanog in tumorigenesis and cancer stem cells.
@ast
Emerging role of nanog in tumorigenesis and cancer stem cells.
@en
type
label
Emerging role of nanog in tumorigenesis and cancer stem cells.
@ast
Emerging role of nanog in tumorigenesis and cancer stem cells.
@en
prefLabel
Emerging role of nanog in tumorigenesis and cancer stem cells.
@ast
Emerging role of nanog in tumorigenesis and cancer stem cells.
@en
P2093
P2860
P356
P1476
Emerging role of nanog in tumorigenesis and cancer stem cells.
@en
P2093
Luis E Iv Santaliz-Ruiz
Matthew Old
Quintin Pan
Theodoros N Teknos
Xiujie Xie
P2860
P304
P356
10.1002/IJC.28690
P577
2014-01-13T00:00:00Z